Company Filing History:
Years Active: 2024-2025
Title: **Mi Seon BAE: Innovator in Pain Therapeutics**
Introduction
Mi Seon BAE is a notable inventor based in Yongin-si, South Korea, recognized for his contributions to pharmacology through innovative therapeutic solutions. With a focus on addressing complex medical conditions, his inventions aim to improve patient outcomes.
Latest Patents
BaE holds a significant patent titled "Dual modulator of mGluR5 and 5-HT2A receptor, and use thereof." This patented technology discloses a dual modulator that operates as both a modulator of the mGluR5 receptor and as an antagonist for the 5-HT2A receptor. The potential applications of this compound lie in its use as a therapeutic agent for pain management, representing a promising advancement in the field of pain therapeutics.
Career Highlights
Mi Seon BAE currently works at Vivozon, Inc., a company dedicated to the development of novel therapeutics aimed at treating various diseases. His efforts in research and development have positioned him as a key player in the industry.
Collaborations
Throughout his career, BAE has collaborated with talented colleagues including Dae Kyu CHOI and Hyo Jin KIM. These partnerships have fostered an environment of innovation and have significantly contributed to the advancements in their shared field of research.
Conclusion
With a commitment to innovation and collaboration, Mi Seon BAE continues to make strides in the development of therapeutic agents. His patent showcases the potential for novel approaches in pain treatment, and his work at Vivozon, Inc. exemplifies the critical role of inventors in enhancing medical care.